Antithrombin
Antithrombin, also known as antithrombin-III, ATIII or AT3 and encoded by SERPINC1, is the most important serine protease inhibitor in plasma. It regulates the blood coagulation cascade by inhibiting thrombin and several activated clotting factors. Browse Assay Genie's current range of Antithrombin research reagents below, or read on for the biology behind the target.
Antithrombin is a plasma protease inhibitor and the principal serine protease inhibitor that regulates the blood coagulation cascade. It inhibits thrombin, matriptase-3/TMPRSS7 and the activated factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin, which is why the protein is central to studies of anticoagulant mechanisms. Researchers working with an antithrombin protein or measuring it with an antithrombin ELISA kit are typically interested in this heparin-dependent control of coagulation proteases.
The protein belongs to the serpin superfamily and is secreted into the extracellular space. According to the NCBI Gene summary, the mature protein has two functional domains: a heparin-binding domain at the N-terminus and a reactive site domain at the C-terminus. The SERPINC1 gene encodes the protein, and the mouse ortholog is Serpinc1. HGNC places it in the serpin peptidase inhibitors gene group.
Numerous mutations have been identified in the antithrombin gene. Many of them cause antithrombin-III deficiency, which is a strong risk factor for thrombosis. A reduction in the serum level of the protein is also associated with severe cases of Coronavirus Disease 19 (COVID-19). Earlier names for the gene include serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1, and serpin peptidase inhibitor, clade C (antithrombin), member 1. Other aliases include ATIII, AT3 and MGC22579. An antithrombin antibody is a common tool for detecting the protein in research on these topics.
Antithrombin is the most important plasma serine protease inhibitor regulating the coagulation cascade, acting on thrombin and factors IXa, Xa and XIa.
Its inhibitory activity is greatly enhanced by heparin, and the mature protein carries an N-terminal heparin-binding domain.
Mutations in SERPINC1 often cause antithrombin-III deficiency, which is a strong risk factor for thrombosis.
A reduced serum level of antithrombin is associated with severe cases of Coronavirus Disease 19.
Antithrombin is a plasma serine protease inhibitor that regulates the blood coagulation cascade. It inhibits thrombin, matriptase-3/TMPRSS7 and factors IXa, Xa and XIa. Heparin greatly enhances this inhibitory activity. Check the datasheet of any product for its validated reactivity.
The protein is also called antithrombin-III, AT-III, ATIII and AT3. The gene symbol is SERPINC1, short for serpin family C member 1. Older names include serpin peptidase inhibitor, clade C (antithrombin), member 1, and the alias MGC22579.
Yes. Many mutations in the gene cause antithrombin-III deficiency, a strong risk factor for thrombosis. A lower serum level of the protein is also associated with severe COVID-19. The mouse ortholog is Serpinc1, which may be relevant to model studies.
Coagulation proteases inhibited by antithrombin, and related targets in the blood clotting cascade.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01008; product specifications from Assay Genie datasheets.